Seeking Alpha

ADR's of Edap TMS (EDAP +17.8%) jump today on the back of a postitive article in Seeking Alpha,...

ADR's of Edap TMS (EDAP +17.8%) jump today on the back of a postitive article in Seeking Alpha, calling it the 'holy grail' in the fight against prostate cancer. Its recent disclosure of test data on its Ablatherm-HIFU - which uses High-Intensity Focused Ultrasound to eviscerate localized prostate cancer - shows it's testing progress has advanced well beyond the stage of laboratories and mice, and is highly likely to receive FDA approval.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|